Reproducibility of uroflow measurement: Experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia

Urology

Volumn 47, Issue 5, 1996, Pages 658-663

  Feneley, Mark R ^a   Dunsmuir, William D ^b   Pearce, Jenny ^b   Kirby, Roger S ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PLACEBO;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REPRODUCIBILITY; URINE FLOW RATE; URINE VOLUME; UROFLOWMETRY;

EID: 0029929947     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00014-3     Document Type: Article

References (16)

1. Agency for Health Care Policy and Research: Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guidelines, No. 8. AHCPR No. 94-0582, 1994.
2. Barry MJ, Girman CJ, O'Leary MP, Walker-Corkery ES, Binkowitz BS, Cockett ATK, Guess HA, and BPH Treatment Outcomes Study Group: Using repeated measures of symptom score, uroflow, and prostate specific antigen in the clinical management of prostate disease. J Urol 153: 99-103, 1995.
3. Blaivas JG: Pathophysiology and differential diagnosis of benign prostatic obstruction. Urology 32 (suppl): 5-10, 1988.
4. Siroky MB, Olsson CA, and Krane RJ: The flow rate nomogram: II. Clinical correlation. J Urol 123: 208-210, 1980.
5. Drach GW, Layton T, and Bottaccini MR: A method of adjustment of male peak urinary flow rate for varying age and volume voided. J Urol 128: 960-962, 1982.
6. Haylen BT, Ashby D, Sutherst JR, Frazer MI, and West CR: Maximum and average urine flow rates in normal male and female populations - the Liverpool nomograms. Br J Urol 64: 30-38, 1989.
7. Drach GW, Layton TN, and Binard WJ: Male peak urinary flow rate: relationships to volume voided and age. J Urol 122: 210-214, 1979.
8. Golomb J, Lindner A, Siegel Y, and Korczak D: Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J Urol 147: 1044-1047, 1992.
9. Grino PB, Bruskewitz R, Blaivas JG, Siroky MB, Andersen JT, Cook T, and Stoner E: Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. J Urol 149: 339-341, 1993.
10. Shoukry I, Susset JG, Elhilali MM, and Dutarte D: Role of uroflowmetry in the assessment of lower urinary tract obstruction in adult males. Br J Urol 47: 559-566, 1975.
11. Gleason DM, Bottaccini MR, Drach GW, and Layton TN: Urinary flow velocity as an index of male voiding function. J Urol 128: 1363-1367, 1982.
12. Chancellor MB, Blaivas JG, Kaplan SA, and Axelrod S: Bladder outlet obstruction versus impaired detrusor contractility: the role of uroflow. J Urol 145: 810-812, 1991.
13. Abrams PH: Prostatism and prostatectomy: the value of urine flow rate measurement in the pre-operative assessment for operation. J Urol 117: 70-71, 1977.
14. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, and Feneley RC: The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 121: 640-642, 1979.
15. McLoughlin J, Gill KP, Abel PD, and Williams G: Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol 66: 303-305, 1990.
16. Jensen KME, Jorgensen JB, and Mogensen P: Urodynamics in prostatism: I. Prognostic value of uroflowmetry. Scand J Urol Nephrol 22: 109-117, 1988.